Table 1.
N (%) | |
---|---|
HRTa is effective for menopausal and related symptoms | 74 (64.9) |
Discussion of preclinical data that showed favorable effects for HRT | 57 (50.0) |
Statements challenging/criticizing unfavorable studies | |
Against WHIb | 89 (78.1) |
Against MWSc | 29 (25.4) |
Statements that HRTa may decrease life-threatening and other serious outcomes | |
Breast cancer | 5 (4.4) |
Cardiovascular disease | 36 (31.6) |
Stroke | 2 (1.8) |
Dementia | 28 (24.6) |
Ovarian cancer | 0 |
Endometrial cancer | 2 (1.8) |
Colorectal cancer | 23 (20.2) |
Osteoporosis/fractures | 56 (49.1) |
Other | |
Hypertension | 3 (2.6) |
Diabetes mellitus | 3 (2.6) |
Depression | 10 (8.8) |
Metabolic syndrome | 2 (1.8) |
Osteoarthritis | 3 (2.6) |
aHRT: hormone replacement therapy; bWHI: Women’s Health Initiative; cMWS: Millon Women Study